{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:05:35Z","timestamp":1781499935317,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1245\/aso.2004.12.042","type":"journal-article","created":{"date-parts":[[2004,8,17]],"date-time":"2004-08-17T01:00:07Z","timestamp":1092704407000},"page":"837-845","source":"Crossref","is-referenced-by-count":33,"title":["Isolated Limb Perfusion: What Is the Evidence for Its Use?"],"prefix":"10.1245","volume":"11","author":[{"given":"Eva M.","family":"Noorda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.","family":"Vrouenraets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omgo E.","family":"Nieweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits","family":"van Coevorden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin B. R.","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1-151757","volume-title":"Evidence-based Medicine: How to Practise and Teach EBM","author":"DL Sackett","year":"2000","unstructured":"Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based Medicine: How to Practise and Teach EBM Edinburgh: Churchill Livingston: 2000."},{"key":"CR2","first-page":"95","volume":"44","author":"JD Urschel","year":"2001","unstructured":"Urschel JD, Goldsmith CH, Tandan VR, Miller JD. Users? guide to evidence-based surgery: how to use an article evaluating surgical interventions. Can J Surg 2001;44:95?100.","journal-title":"Can J Surg"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1200\/JCO.1998.16.9.2906","volume":"16","author":"H Schraffordt Koops","year":"1998","unstructured":"Schraffordt Koops H, Vaglini M, Suciu S, et al. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. J Clin Oncol 1998;16:2906?12.","journal-title":"J Clin Oncol"},{"key":"CR4","first-page":"343","volume":"86","author":"CM Balch","year":"1979","unstructured":"Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery 1979;86:343?51.","journal-title":"Surgery"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0748-7983(97)80134-5","volume":"23","author":"NJ Fenn","year":"1997","unstructured":"Fenn NJ, Horgan K, Johnson RC, Hughes LE, Mansel RE. A randomized controlled trial of prophylactic isolated cytotoxic perfusion for poor-prognosis primary melanoma of the lower limb. Eur J Surg Oncol 1997;23:6?9.","journal-title":"Eur J Surg Oncol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00000658-198412000-00016","volume":"200","author":"F Ghussen","year":"1984","unstructured":"Ghussen F, Nagel K, Groth W, Muller JM, Stutzer H. A prospective randomized study of regional extremity perfusion in patients with malignant melanoma. Ann Surg 1984;200:764?8.","journal-title":"Ann Surg"},{"key":"CR7","first-page":"242","volume":"89","author":"BBR Kroon","year":"2000","unstructured":"Kroon BBR, Nieweg OE. Management of malignant melanoma. Ann Chir Gynaecol 2000;89:242?50.","journal-title":"Ann Chir Gynaecol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1200\/JCO.1991.9.12.2091","volume":"9","author":"L Hafstrom","year":"1991","unstructured":"Hafstrom L, Rudenstam CM, Blomquist E, et al. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group. J Clin Oncol 1991;9:2091?4.","journal-title":"J Clin Oncol"},{"key":"CR9","first-page":"S18","volume":"10","author":"RB Takkenberg","year":"2003","unstructured":"Takkenberg RB, et al. Does isolated limb perfusion prolong the limb recurrence-free interval after several episodes of excisional surgery for limb recurrences of melanoma? Ann Surg Oncol, 2003;10?S18","journal-title":"Ann Surg Oncol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/bjs.1800831004","volume":"83","author":"BC Vrouenraets","year":"1996","unstructured":"Vrouenraets BC, Nieweg OE, Kroon BBR. Thirty-five years of isolated limb perfusion for melanoma: indications and results. Br J Surg 1996;83:1319?28.","journal-title":"Br J Surg"},{"key":"CR11","unstructured":"Fraker D, Alexander H, Ross M, et al. A phase III trial of isolated limb perfusion for extremity melanoma comparing melphalan alone versus melphalan plus tumor necrosis factor (TNF) plus interferon gamma. Ann Surg Oncol, 2002;S8."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00008390-199404000-00008","volume":"4","author":"BA Kapteijn","year":"1994","unstructured":"Kapteijn BA, Klaase JM, van Geel AN, Eggermont AMM, Kroon BBR. Results of regional isolated perfusion for locally inoperable melanoma of the limbs. Melanoma Res 1994;4:135?8.","journal-title":"Melanoma Res"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00008390-199910000-00009","volume":"9","author":"D Li\u00e9nard","year":"1999","unstructured":"Li\u00e9nard D, et al. Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study. Melanoma Res 1999;9:491?502.","journal-title":"Melanoma Res"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/bjs.1800830425","volume":"83","author":"S Hill","year":"1996","unstructured":"Hill S, Thomas JM. Use of the carbon dioxide laser to manage cutaneous metastases from malignant melanoma. Br J Surg 1996;83:509?12.","journal-title":"Br J Surg"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0748-7983(97)93726-4","volume":"23","author":"LJ Strobbe","year":"1997","unstructured":"Strobbe LJ, Nieweg OE, Kroon BBR. Carbon dioxide laser for cutaneous melanoma metastases: indications and limitations. Eur J Surg Oncol 1997;23:435?8.","journal-title":"Eur J Surg Oncol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(95)90463-8","volume":"345","author":"J Overgaard","year":"1995","unstructured":"Overgaard J, Gonzalez GD, Hulshof MC, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995;345:540?3.","journal-title":"Lancet"},{"key":"CR17","first-page":"17","volume":"149","author":"FK Storm","year":"1979","unstructured":"Storm FK, Sparks FC, Morton DL. Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guerin and hyperthermic perfusion. Surg Gynecol Obstet 1979;149:17?21.","journal-title":"Surg Gynecol Obstet"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/1097-0142(19880315)61:6<1071::AID-CNCR2820610603>3.0.CO;2-T","volume":"61","author":"P von Wussow","year":"1988","unstructured":"von Wussow P, Block B, Hartmann F, Deicher H. Intralesional interferon-alpha therapy in advanced malignant melanoma. Cancer 1988;61:1071?4.","journal-title":"Cancer"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00008390-199712000-00010","volume":"7","author":"LJ Strobbe","year":"1997","unstructured":"Strobbe LJ, Hart AA, Rumke P, Israels SP, Nieweg OE, Kroon BB. Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma. Melanoma Res 1997;7:507?12.","journal-title":"Melanoma Res"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1200\/JCO.1996.14.2.479","volume":"14","author":"DL Fraker","year":"1996","unstructured":"Fraker DL, Alexander HR, Andrich M, Rosenberg SA. Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study. J Clin Oncol 1996;14:479?89.","journal-title":"J Clin Oncol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/sonc.2002.34119","volume":"29","author":"CR Rossi","year":"2002","unstructured":"Rossi CR, Foletto M, Pilati P, Mocellin S, Lise M. Isolated limb perfusion in locally advanced cutaneous melanoma. Semin Oncol 2002;29:400?9.","journal-title":"Semin Oncol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000658-198209000-00009","volume":"196","author":"SA Rosenberg","year":"1982","unstructured":"Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982;196:305?15.","journal-title":"Ann Surg"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00000658-199612000-00011","volume":"224","author":"AMM Eggermont","year":"1996","unstructured":"Eggermont AMM, Schraffordt Koops H, Klausner JM, et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg 1996;224:756?64.","journal-title":"Ann Surg"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.1992.10.1.52","volume":"10","author":"D Li\u00e9nard","year":"1992","unstructured":"Li\u00e9nard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992;10:52?60.","journal-title":"J Clin Oncol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0360-3016(97)00923-1","volume":"40","author":"AF Olieman","year":"1998","unstructured":"Olieman AF, Pras E, van Ginkel RJ, Molenaar WM, Schraffordt Koops H, Hoekstra HJ. Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-alpha and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 1998;40:807?14.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1245\/ASO.2003.03.076","volume":"10","author":"B van Etten","year":"2003","unstructured":"van Etten B, van Geel AN, de Wilt JH, Eggermont AMM. Fifty tumor necrosis factor-based isolated limb perfusions for limb salvage in patients older than 75 years with limb-threatening soft tissue sarcomas and other extremity tumors. Ann Surg Oncol 2003;10:32?7.","journal-title":"Ann Surg Oncol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/ejso.2000.0979","volume":"26","author":"FJ Lejeune","year":"2000","unstructured":"Lejeune FJ, Pujol N, Li\u00e9nard D, et al. Limb salvage by neoadjuvant isolated perfusion with TNF alpha and melphalan for non-resectable soft tissue sarcoma of the extremities. Eur J Surg Oncol 2000;26:669?78.","journal-title":"Eur J Surg Oncol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1129::AID-CNCR11>3.0.CO;2-1","volume":"79","author":"M Gutman","year":"1997","unstructured":"Gutman M, Inbar M, Lev-Shlush D, et al. High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation. Cancer 1997;79:1129?37.","journal-title":"Cancer"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1200\/JCO.1988.6.5.854","volume":"6","author":"HD Suit","year":"1988","unstructured":"Suit HD, Mankin HJ, Wood WC, et al. Treatment of the patient with stage M0 soft tissue sarcoma. J Clin Oncol 1988;6:854?62.","journal-title":"J Clin Oncol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/1097-0142(19940315)73:6<1652::AID-CNCR2820730617>3.0.CO;2-X","volume":"73","author":"KK Tanabe","year":"1994","unstructured":"Tanabe KK, Pollock RE, Ellis LM, Murphy A, Sherman N, Romsdahl MM. Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas. Cancer 1994;73:1652?9.","journal-title":"Cancer"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","volume":"359","author":"B O?Sullivan","year":"2002","unstructured":"O?Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002;359:2235?41.","journal-title":"Lancet"},{"key":"CR32","first-page":"59","volume":"201","author":"FR Eilber","year":"1985","unstructured":"Eilber FR, Guiliano AE, Huth J, Mirra J, Morton DL. High-grade soft-tissue sarcomas of the extremity: UCLA experience with limb salvage. Prog Clin Biol Res 1985;201:59?74.","journal-title":"Prog Clin Biol Res"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ssu.2980040106","volume":"4","author":"JF Huth","year":"1988","unstructured":"Huth JF, Eilber FR. Patterns of metastatic spread following resection of extremity soft-tissue sarcomas and strategies for treatment. Seminin Surg Oncol 1988;4:20?6.","journal-title":"Seminin Surg Oncol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1002\/1097-0142(19930601)71:11<3685::AID-CNCR2820711135>3.0.CO;2-6","volume":"71","author":"EA Levine","year":"1993","unstructured":"Levine EA, Trippon M, Das Gupta TK. Preoperative multimodality treatment for soft tissue sarcomas. Cancer 1993;71:3685?9.","journal-title":"Cancer"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/BF02305541","volume":"4","author":"WJ Temple","year":"1997","unstructured":"Temple WJ, Temple CL, Arthur K, Schachar NS, Paterson AH, Crabtree TS. Prospective cohort study of neoadjuvant treatment in conservative surgery of soft tissue sarcomas. Ann Surg Oncol 1997;4:586?90.","journal-title":"Ann Surg Oncol"},{"issue":"(Suppl 2):","key":"CR36","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1093\/annonc\/3.suppl_2.S67","volume":"3","author":"A Azzarelli","year":"1992","unstructured":"Azzarelli A, Quagliuolo V, Fissi S, et al. Intra-arterial induction chemotherapy for soft tissue sarcomas. Ann Oncol, 1992;3(Suppl 2):S67?S70","journal-title":"Ann Oncol"},{"key":"CR37","first-page":"564","volume":"178","author":"JM Klaase","year":"1994","unstructured":"Klaase JM, Kroon BBR, van Geel AN, et al. Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion. J Am Coll Surg 1994;178:564?72.","journal-title":"J Am Coll Surg"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/cncr.11648","volume":"98","author":"EM Noorda","year":"2003","unstructured":"Noorda EM, Vrouenraets BC, Nieweg OE, van Coevorden F, van Slooten GW, Kroon BBR. Isolated limb perfusion with TNF-alpha and melphalan for unresectable soft tissue sarcoma of the extremities. Cancer 2003;98:1483?90.","journal-title":"Cancer"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00000658-197705000-00008","volume":"185","author":"ET Krementz","year":"1977","unstructured":"Krementz ET, Carter RD, Sutherland CM, Hutton I. Chemotherapy of sarcomas of the limbs by regional perfusion. Ann Surg 1977;185:555?64.","journal-title":"Ann Surg"},{"key":"CR40","first-page":"149","volume":"162","author":"PM Lehti","year":"1986","unstructured":"Lehti PM, Moseley HS, Janoff K, Stevens K, Fletcher WS. Improved survival for soft tissue sarcoma of the extremities by regional hyperthermic perfusion, local excision and radiation therapy. Surg Gynecol Obstet 1986;162:149?52.","journal-title":"Surg Gynecol Obstet"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/1097-0142(19890801)64:3<616::AID-CNCR2820640309>3.0.CO;2-8","volume":"64","author":"JM Klaase","year":"1989","unstructured":"Klaase JM, Kroon BBR, Benckhuijsen C, van Geel AN, Albus-Lutter CE, Wieberdink J. Results of regional isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities. Cancer 1989;64:616?21.","journal-title":"Cancer"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-4684-5766-7_22","volume":"267","author":"F Di Filippo","year":"1990","unstructured":"Di Filippo F, Carlini S, Cavalier E, et al. The role of hyperthermic perfusion in the treatment of tumors of the extremities. Adv Exp Med Biol 1990;267:223?34.","journal-title":"Adv Exp Med Biol"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/archsurg.1992.01420100027005","volume":"127","author":"HS Moseley","year":"1992","unstructured":"Moseley HS. An evaluation of two methods of limb salvage in extremity soft-tissue sarcomas. Arch Surg 1992;127:1169?73.","journal-title":"Arch Surg"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1096-9098(199609)63:1<3::AID-JSO2>3.0.CO;2-9","volume":"63","author":"CR Rossi","year":"1996","unstructured":"Rossi CR, Foletto M, Alessio S, et al. Limb-sparing treatment for soft tissue sarcomas: influence of prognostic factors. J Surg Oncol 1996;63:3?8.","journal-title":"J Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/ASO.2004.12.042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/ASO.2004.12.042\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/ASO.2004.12.042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T04:51:28Z","timestamp":1559623888000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/ASO.2004.12.042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1245\/aso.2004.12.042","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}